Using Pharmacokinetics to Assure Chemical Food Safety Blog Using Pharmacokinetics to Assure Chemical Food Safety As a veterinarian, I’m responsible for the health and welfare of my animal patients. Sometimes,…Certara2017 年 5 月 12 日
Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications Publication Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications Danielle Pillsbury2017 年 5 月 1 日
Effect of Disease-related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats Publication Effect of Disease-related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats Danielle Pillsbury2017 年 5 月 1 日
Isoniazid Clearance is Impaired Among Human Immunodeficiency Virus/Tuberculosis Patients with High Levels of Immune Activation Publication Isoniazid Clearance is Impaired Among Human Immunodeficiency Virus/Tuberculosis Patients with High Levels of Immune Activation Danielle Pillsbury2017 年 4 月 1 日
The Model-informed Precision Dosing Revolution Is Coming Blog The Model-informed Precision Dosing Revolution Is Coming Modeling and simulation (M&S) has been widely accepted and adopted by biopharmaceutical companies and global…Certara2017 年 3 月 7 日
CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites Publication CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites Danielle Pillsbury2017 年 3 月 1 日
A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor Publication A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor Danielle Pillsbury2017 年 1 月 10 日
Clarification of Contraceptive Drug Pharmacokinetics in Obesity Publication Clarification of Contraceptive Drug Pharmacokinetics in Obesity Danielle Pillsbury2017 年 1 月 1 日
Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer Publication Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer Danielle Pillsbury2016 年 12 月 18 日
Phoenix IVIVC Toolkit Brochure Phoenix IVIVC 工具箱 探索 IVIVC Toolkit 的全面功能。Danielle Pillsbury2016 年 12 月 14 日